Search blog

Blog

Last week, life sciences patent professionals from around the world gathered at London’s Hallam Conference Centre for IAM’s second annual Pharma and Biotech IP Summit – the first ever IAM event to be held on UK home turf. Delegates – and there were twice as many in attendance than were at our first summit in Munich in 2016 – were treated to insightful presentations and discussions by seasoned in-house and private practice professionals on a range of key legal,
Read more

RPX has acquired a tranche of patent assets from the Intellectual Ventures Invention Science Fund in what is the first such deal between the firms. So far two sets of rights have shown up on the USPTO assignment database — one for 35 granted patents and applications and another for 22 — and a spokesperson for RPX confirmed that 66 assets had changed hands in total.
IV has been in patent-selling mode for some time now. As this blog reported last year, it has ramped up its
Read more

The vast majority of patent disputes in the US settle before they end up in court. One reason for this, it is claimed, is because scared defendants are worried into making suits go away by aggressive plaintiffs (trolls) who give them a choice of settlement at one price or fighting a suit at a higher price. And, undoubtedly, there is an element of that involved.
However, there is a lot more on top. For example, looking from the plaintiff’s perspective there are also significant
Read more

The top official in the Indian Patent Office’s Chennai branch was detained along with one colleague earlier this month on charges of graft. While digital technologies and transparency initiatives have generally made India’s IP granting authorities more accountable in recent years, the arrests suggest that corruption has not been fully stamped out of the patent office.
The main official implicated was S P Subramaniyan, a deputy controller of patents and designs in the patent
Read more

UPDATE 2/16/2018: Louis Carbonneau of Tangible IP has been in touch to say that they brokered the deal between France Brevets and Didi Chuxing and that it included a total of 140 US and non-US assets.
In the still relatively nascent ride-sharing market there are two clear leaders – Uber from the US and Didi Chuxing from China. Both are relative minnows in IP terms, but the pair have been busy in the secondary market of late which for the latter is particularly significant as it
Read more

A new study has found that increasing workforce diversity – in terms of gender, race and sexual orientation – leads to a rise in innovation, specifically with regard to the number of new products announced and how many patents that are created and cited.
Published in December, the paper - “Do Pro-Diversity Policies Improve Corporate Innovation” - was co-authored by Roger Mayer and Richard Warr of North Carolina State University, and Jing Zhao of Portland State
Read more

After a year in which it sold off a significant number of assets, Intellectual Discovery (ID) got back in the acquisition game in late December, assignment records show. It looks like the first portfolio the Korean patent fund has bought from a foreign company since the departure of former CEO Kwang Jun Kim in October 2016.
ID acquired 16 US patents in all in two separate transactions on 26th December 2017. The two assignors, Gigabit Solutions LLC and Ladon Solutions LLC, both list
Read more

Earlier this month, the Clarivate Analytics 2017 Top 100 Global Innovators report was released. It was the seventh in an annual series of reports that identifies the world’s leading innovators, celebrates their achievements and contributions to enriching the world through innovation, and provides some insight into why they are successful.
This year long-time members of the 100 were joined by a selection of newcomers, including the likes of Facebook, Hon Hai, Nichia and Western
Read more

A high-profile group of academics and senior IP stakeholders - including former Chief Judge of the Court of Appeals for the Federal Circuit Paul Michel and former USPTO Director David Kappos - have written to Department of Justice antitrust head Makan Delrahim to voice their support for what they characterise as his commitment to apply antitrust law equally to both those who develop patented technology and those who implement standards-based technology.
The group also criticises a letter
Read more

A new study of the global CRISPR patent landscape released today provides the most detailed insight yet into how entities are seeking to protect their inventions relating to the revolutionary technology.
Speaking exclusively to IAM, the report’s author Aditi Das outlined its notable findings, such as DowDuPont’s surprise emergence as the biggest IP holder in the field. She also described the chaotic nature of the CRISPR patent landscape – which could create licensing
Read more